|کد مقاله||کد نشریه||سال انتشار||مقاله انگلیسی||ترجمه فارسی||نسخه تمام متن|
|5665967||1407779||2017||3 صفحه PDF||ندارد||دانلود کنید|
â¢Three hundred twenty-eight E. coli, 35 Klebsiella spp., (1 K. oxytoca and 34 K. pneumoniae) and 16 Enterobacter spp. (1 E. aerogenes and 15 E. cloacae) well-characterized isolates nonsusceptible to third-generation cephalosporins were tested by broth microdilution antimicrobial susceptibility testing.â¢The following concentration ranges were included: ampicillin/sulbactam (2/4â16/4Â mg/L), amoxicillin/clavulanic acid (4/2â32/2Â mg/L), piperacillin/tazobactam (1/4â128/4Â mg/L), mecillinam (0.5â64Â mg/L), mecillinam/clavulanic acid (0.5/4â64/4Â mg/L), and temocillin (1â128Â mg/L).â¢Our study gives insight in Î²-lactam MIC distributions of a collection of well-characterized German 3GCREB isolates. Several Î²-lactam antibiotics showed good in vitro activity and may serve as treatment options for infections.
As part of the multicenter Antibiotic Therapy Optimisation Studyâthe largest study on the prevalence of third-generation cephalosporin-resistant Enterobacteriaceae carriage upon hospital admissionâminimum inhibitory concentration values were generated for ampicillin/sulbactam, amoxicillin/clavulanic acid, piperacillin/tazobactam, mecillinam, mecillinam/clavulanic acid, and temocillin against third-generation cephalosporin-resistant Escherichia coli, Klebsiella species and Enterobacter species.
Journal: Diagnostic Microbiology and Infectious Disease - Volume 87, Issue 1, January 2017, Pages 71-73